OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
March 01, 2012
Taste-masking is an important consideration to ensure patient compliance.
Experts in solid dosage discuss the formulation and manufacture of multilayer tablets.
FDA answers key questions about the October 2011 guidance on using physical–chemical identifiers in solid oral dosage products to help prevent and avoid counterfeiting.
The pharma industry has reached the long-dreaded patent cliff, but for copycat products, business is booming.
JHS Secures Four Sterile Parenteral Products Manufacturing Contracts; Samsung Biologics, Biogen Idec Establish Biosimilars Joint Venture; and More.
February 23, 2012
Pfizer has signed an agreement with the Chinese biopharmaceutical company Zhejiang Hisun Pharmaceuticals with the objective of establishing a $545-million joint venture to develop and commercialize branded generic medicines in both China and the global market.
February 17, 2012
PDA organizes this conference to address the technical and regulatory issues related to parenteral packaging. Chemical, physical and microbiological aspects will be considered and current regulatory challenges will be discussed. Two Training Courses on Container Closure Development or Selection and Utilization of Glass Containers in Pharmaceutical Packaging will be given.
February 15, 2012
The author discusses the relative advantages and disadvantages of lyophilization in vials and dual-chamber systems.
February 02, 2012
A nickel's worth of free advice to the competition could come at the expense of your bottom line.
Debottlenecking downstream mAb purification.